Introduction
What causes Moyamoya disease? The condition develops when the large arteries at the base of the brain, especially the internal carotid arteries and their major branches, become progressively narrowed or blocked for reasons that are not always fully understood. As this happens, the brain responds by forming a network of tiny collateral blood vessels in an attempt to preserve blood flow. These fragile vessels create the characteristic “puff of smoke” appearance seen on angiographic imaging, which is the meaning of the term moyamoya. The disease arises through a combination of vascular remodeling, genetic susceptibility, immune and inflammatory influences, and, in some cases, other medical disorders that damage or stress the cerebral arteries.
The causes are best understood as a set of interacting biological processes rather than a single trigger. In some people, a strong inherited predisposition plays the leading role. In others, the disease appears alongside another condition that alters blood vessel structure or function. Environmental and hormonal influences may also affect whether the disease develops and how quickly it progresses. Understanding these pathways explains why Moyamoya disease can appear in childhood or adulthood and why the underlying cause may differ from one patient to another.
Biological Mechanisms Behind the Condition
The central event in Moyamoya disease is progressive stenosis, or narrowing, of the intracranial arteries that supply the brain. Under normal conditions, large arteries carry oxygen-rich blood efficiently to the brain, while smaller downstream vessels maintain stable flow even when demand changes. In Moyamoya disease, the inner layer of the affected arteries, known as the intima, thickens abnormally. Smooth muscle cells and extracellular matrix accumulate in the vessel wall, and the lumen gradually becomes narrower. This reduces blood delivery to brain tissue and creates chronic cerebral hypoperfusion.
The body responds to reduced flow by stimulating angiogenesis, the formation of new blood vessels. However, the collateral vessels that develop in Moyamoya disease are not robust or structurally normal. They are thin-walled, tortuous, and inefficient. Instead of restoring normal circulation, they represent an emergency adaptation to ischemia. Their fragility also increases the risk of hemorrhage in some patients. In this way, the disease reflects both arterial narrowing and an abnormal repair response by the vascular system.
Several biological pathways appear to contribute to this process. Abnormal signaling in vascular growth factors, changes in endothelial cell behavior, chronic low-grade inflammation, and altered smooth muscle cell activity may all promote the progressive remodeling of the cerebral arteries. The disorder is not caused by a single blocked vessel in the usual sense. Rather, it develops from a diffuse pathological change in vessel wall biology that gradually transforms the normal arterial anatomy of the brain.
Primary Causes of Moyamoya Disease
Genetic susceptibility is one of the strongest known causes of Moyamoya disease, especially in populations where the condition is more common. The RNF213 gene has been most closely associated with the disease, particularly in East Asian populations. Variants in this gene do not guarantee disease, but they significantly increase risk. RNF213 is thought to influence vascular development and the integrity of blood vessel walls. When altered, it may make cerebral arteries more vulnerable to progressive stenosis and abnormal collateral formation. Because the gene is involved in vascular remodeling, its effects can shape how arteries respond to injury, inflammation, or metabolic stress.
Primary idiopathic vascular remodeling is another major cause. In many patients, no single external trigger is identified. Instead, the disease seems to begin with an intrinsic abnormality of the arterial wall. The cells lining the vessels may behave in an exaggerated repair pattern, with increased intimal thickening and narrowing. Over time, repeated or sustained remodeling can compromise blood flow. This mechanism explains why Moyamoya can appear without obvious preceding illness or injury. The arteries gradually change shape and caliber as part of a poorly regulated biological process.
Autoimmune or inflammatory vessel injury may also contribute in some cases. When the immune system becomes persistently activated, inflammatory molecules can affect the endothelial lining of the arteries. Endothelial dysfunction alters the normal balance between vessel constriction, relaxation, and repair. In the cerebral circulation, this can encourage scarring, narrowing, and secondary collateral vessel growth. Although inflammation is not always the initiating cause, it can amplify the disease process by accelerating arterial remodeling and impairing normal blood vessel homeostasis.
Hemodynamic stress can further drive the disease once narrowing begins. The brain requires a constant and substantial blood supply, and if flow through the main arteries declines, shear stress and pressure patterns change throughout the vascular network. These altered forces can push the body toward compensatory vessel growth. Unfortunately, the compensation is incomplete. Instead of restoring normal perfusion, the system produces fragile alternative channels that characterize Moyamoya disease. Thus, a primary reduction in arterial caliber can lead to a self-perpetuating cycle of ischemia and abnormal collateral formation.
Contributing Risk Factors
Several factors may increase the likelihood of developing Moyamoya disease, even if they do not directly cause it on their own. Genetic influences remain the most important of these. Family clustering is well described, and relatives of affected individuals have a higher risk than the general population. In some families, the disease may reflect inherited variants affecting vessel development, inflammatory regulation, or endothelial function. Genetic background can also influence the age of onset, severity, and whether the disease develops on one or both sides of the brain.
Environmental exposures may act as modifiers of risk. While no single exposure has been proven to cause Moyamoya disease in most patients, environmental stressors that affect vascular health may contribute indirectly. Chronic exposure to conditions that damage endothelium, disrupt immune regulation, or increase oxidative stress could make the cerebral arteries more susceptible to abnormal remodeling. These influences are usually considered secondary factors, but they may help explain why the disease emerges in some individuals with a genetic predisposition and not in others.
Infections have been proposed as possible triggers in certain cases. Some infectious processes can produce inflammation in or around blood vessels, leading to temporary or lasting endothelial dysfunction. If the vessel wall is already vulnerable because of genetic or developmental factors, infection-related immune activation may accelerate stenosis. The exact role of infection remains uncertain, but it is biologically plausible that repeated inflammatory insults can contribute to vascular remodeling in susceptible patients.
Hormonal changes may also influence disease expression. Moyamoya disease is diagnosed more often in females than males, suggesting that sex-related biology could play a role. Hormones affect endothelial function, vascular tone, and inflammatory signaling. Changes in hormonal balance may therefore alter how cerebral vessels respond to stress or injury. This does not mean hormones are the sole cause, but they may help shape the timing or severity of disease in predisposed individuals.
Lifestyle factors are not established direct causes, but they can influence vascular health in ways that may matter. Conditions associated with poor endothelial function, chronic hypertension, or systemic inflammation can place additional strain on blood vessels. These factors are more likely to modify progression than to initiate the disease. Still, from a biological standpoint, anything that worsens vascular integrity may make the brain’s arteries less able to withstand the remodeling process that defines Moyamoya disease.
How Multiple Factors May Interact
Moyamoya disease is best understood as the result of interacting biological layers. A person may inherit a susceptibility gene that makes the cerebral arteries unusually sensitive to remodeling. That vulnerability may remain silent until another influence, such as inflammation, altered blood flow, or an associated disorder, shifts the balance of vascular repair. Once narrowing begins, the resulting reduction in cerebral perfusion creates additional stress on the vessel wall and promotes further adaptation. The disease can therefore progress through a feedback loop in which narrowed arteries, reduced oxygen delivery, and compensatory collateral formation reinforce one another.
This interaction also explains why the disease varies so much in severity. Two people with similar genetic backgrounds may have different environmental exposures, different immune responses, or different underlying medical conditions. One person may develop slowly progressive stenosis over years, while another has a more aggressive course. The final anatomy reflects not just one cause, but the cumulative effect of multiple signals acting on a susceptible vascular system.
Variations in Causes Between Individuals
The causes of Moyamoya disease differ across individuals because the condition is influenced by several layers of biology. Genetics may dominate in some patients, especially when there is a family history or a known susceptibility variant. In others, the disease may be more closely linked to another medical disorder or to acquired vascular stress. Age is also important. Childhood cases may more often reflect developmental or inherited vulnerability, while adult cases may involve a broader mix of genetic predisposition and secondary triggers.
Health status matters as well. A person with systemic inflammatory disease, thyroid dysfunction, or prior vascular injury may have a different pathway to Moyamoya than someone who develops it without obvious comorbidity. Environmental exposure can further modify the picture. The disease may emerge when a susceptible vascular system encounters repeated stressors that push the arteries toward chronic remodeling. For this reason, the term “Moyamoya disease” covers a biologically diverse group of patients who share a similar vascular endpoint but not always the same initiating cause.
Conditions or Disorders That Can Lead to Moyamoya disease
Some patients develop a Moyamoya pattern in association with other medical disorders. This is often called Moyamoya syndrome rather than primary Moyamoya disease, but the underlying vascular changes are similar. Down syndrome is one of the best-known associations. Individuals with Down syndrome have differences in vascular development and immune regulation that may predispose them to cerebral arterial narrowing. The exact mechanism is not fully defined, but abnormal vessel formation and remodeling appear to be central.
Sickle cell disease can also lead to a Moyamoya-like vascular pattern. In sickle cell disease, red blood cells become rigid and can damage the endothelium, promote inflammation, and reduce oxygen delivery. Repeated vascular injury in the cerebral circulation may trigger stenosis and collateral formation. In this setting, Moyamoya is not the primary disorder, but rather the vascular response to chronic hematologic stress.
Neurofibromatosis type 1 is another associated condition. This genetic disorder can affect the growth and function of blood vessels, making arterial narrowing more likely. The vascular abnormalities seen in neurofibromatosis may overlap with the remodeling process of Moyamoya and produce similar angiographic findings.
Prior cranial irradiation can also trigger Moyamoya changes. Radiation damages endothelial cells and can cause long-term scarring and narrowing of arteries. Over time, the brain’s circulation may respond by forming the small collateral vessels typical of Moyamoya. The delay between exposure and disease can be long, reflecting the slow progression of radiation-induced vascular injury.
Other associated conditions include certain autoimmune diseases, thyroid disorders, and congenital vascular abnormalities. In each case, the common pathway is injury or dysfunction of the vessel wall, leading to compensatory but inefficient arterial remodeling in the brain.
Conclusion
Moyamoya disease develops because the major arteries supplying the brain undergo progressive narrowing, and the body responds by forming fragile collateral vessels. The causes include genetic susceptibility, especially variants linked to vascular remodeling, as well as biological processes such as endothelial dysfunction, inflammation, and abnormal arterial repair. In some people, the disease occurs on its own; in others, it appears alongside medical conditions that injure or stress the cerebral circulation. Environmental and hormonal influences may modify risk, and the interaction of multiple factors often determines when and how the disease develops.
Understanding the causes of Moyamoya disease requires looking at how genes, vessel biology, immune activity, and hemodynamic stress interact over time. The condition is not explained by a single blockage or one external exposure. It arises from a distinctive pattern of vascular change that reflects the brain’s attempt to preserve blood flow in the face of chronic arterial narrowing. That biological sequence is what produces the disease and explains its varied presentation across different individuals.